Insiders Vanda Pharmaceuticals Inc.

Equities

VNDA

US9216591084

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 18:06:28 15/12/2025 GMT			5-day change	1st Jan Change
6.580 ^USD	+5.62%		+7.41%	+37.68%

05:40pm	Vanda Pharmaceuticals Rises on FDA Biologics License Application	DJ
02:23pm	Vanda Pharmaceuticals Inc. Announces Submission of Biologics License Application to FDA for Imsidolimab for Treatment of Generalized Pustular Psoriasis	CI

Insiders

Vanda Pharmaceuticals Inc. Appoints Dr. Tage Honoré to its Board of Directors	17/03/23	CI
Insider Sell: Vanda Pharmaceuticals	07/12/22	MT
H. Thomas Watkins Not Stands for Reelection of Vanda Pharmaceuticals Inc	25/04/22	CI
Insider Sell: Vanda Pharmaceuticals	02/12/21	MT
Vanda Pharmaceuticals Inc. Announces Resignation of Aranthan “Aj” Jones II as the Corporate Affairs and Communications Officer	08/10/21	CI
Insider Sell: Vanda Pharmaceuticals	17/09/21	MT
Insider Sell: Vanda Pharmaceuticals	13/09/21	MT
Insider Trends: 90-Day Insider Buying Trend Scaled Back with Sale of Vanda Pharmaceuticals Shares	27/07/21	MT
Vanda Pharmaceuticals Inc. Announces Resignation of Mihael H. Polymeropoulos as Director	22/04/20	CI
Vanda Pharmaceuticals Inc. Announces Resignation of Gian Piero Reverberi as Senior Vice President and Chief Commercial Officer, Effective as of March 16, 2020	03/03/20	CI
Vanda Pharmaceuticals Inc. Announces Executive Changes, Effective March 15, 2020	20/02/20	CI
Vanda Pharmaceuticals Inc. Announces Board Changes	19/02/20	CI
Vanda Pharmaceuticals Announces Resignation of Gian Piero Reverberi as its Senior Vice President, Chief Commercial Officer, Effective March 16, 2020	21/01/20	CI
Vanda Pharmaceuticals Inc. Hires Scott L. Howell as Its Chief People Officer	06/11/19	CI
Vanda Pharmaceuticals Inc. Appoints Anne Sempowski Ward to Board of Directors	28/10/19	CI
Vanda Pharmaceuticals Announces Management Appointments	21/08/19	CI
Vanda Pharmaceuticals Appoints Phaedra Chrousos to Board of Directors	24/04/19	CI
Vanda Pharmaceuticals Inc. Appoints Timothy Williams as Senior Vice President, General Counsel and Secretary	13/08/18	CI
Vanda Pharmaceuticals Inc. Announces Retirement of Kenneth M. Bate from the Board of Directors	25/04/18	CI
Vanda Pharmaceuticals Inc Announces Resignation of Richard L. Gulino as Senior Vice President, General Counsel and Secretary, Effective May 2, 2018	23/04/18	CI
Paolo Baroldi Notifies His Resignation as Chief Medical Officer of Vanda Pharmaceuticals Inc., Effective March 22, 2017	13/03/17	CI
Vanda Pharmaceuticals, Inc. Announces Howard H. Pien Not Stand to Re-Elect as Director	25/03/16	CI
Vanda Pharmaceuticals Inc. Announces Executive Changes	21/12/15	CI
Kenneth Bate Joins the Board of Directors of Vanda Pharmaceuticals Inc	18/12/15	CI
Vanda Pharmaceuticals, Inc. Appoints Richard Gulino as Senior Vice President, General Counsel and Secretary	14/09/15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Vanda Pharmaceuticals Inc.

Equities

VNDA

US9216591084

Biotechnology & Medical Research

Insiders

Filters